Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women

Scandinavian Journal of Public Health

Volumn 34, Issue 1, 2006, Pages 11-16

  Graff Iversen, Sidsel ^a   Hammar, Niklas ^b   Thelle, Dag S ^c   Tonstad, Serena ^d  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiovascular disease; mortality; oral contraceptives

Indexed keywords

CHOLESTEROL; DESOGESTREL; ETHINYLESTRADIOL; GESTAGEN; LIPID; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DRUG FATALITY; DRUG USE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LIPID BLOOD LEVEL; LUNG CANCER; LYMPHATIC SYSTEM DISEASE; MORTALITY; NORWAY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; STOMACH CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

EID: 32144445911     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940510032239     Document Type: Article

References (21)

1. F.R., Van Rosendaal Hylckama Vlieg A., Tanis B.C., Helmerhorst F.M. Estrogens, progestogens and thrombosis. J Thromb Hemost 2003;1:1371-1380.
2. Beral V., Hermon C., Kay C., Hannaford P., Darby S., Reeves G. Mortality associated with oral contraceptive use: 25 years follow up of cohort of 46 000 women from Royal College of General Practitioners’ oral contraceptive study. Br Med J 1999;318:96-100.
3. Dunn N.R., Thorogood M., Faragher B., et al. Oral contraceptives and myocardial infarction: Results of the MICA case-control study. Br Med J 1999;318:1579-1584.
4. Tanis B.C., van den Bosch Maaj, Kemmeren J.M., et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001;345:1787-1793.
5. Rosenberg L., Palmer J.R., Rao R.S., Shapiro S.M.B. Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 2001;161:1065-1070.
6. Gillum L.A., Mamidipudi S.K., Johnston S.C. Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 2000; 284:72-78.
7. Kumle M., Alsaker E., Lund E. Use of oral contraceptives and risk of cancer, a cohort study. Tidsskr Nor Lægeforen 2003;12:1653-6.
8. World Health Organization. Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. Contraception 1998;57:315-324.
9. Skegg D.C.G. Oral contraception and health. Long term study of mortality shows no overall effect in a developed country. Br Med J 1999;318:69-70.
10. Graff-Iversen S., Tverdal A., Stensvold I. Cardiovascular risk factors in Norwegian women using oral contraceptives: Result from a cardiovascular health screening 1985—88. Contraception 1996;53:337-344.
11. Bjartveit K., Foss P.O., Gjervig T., Lund-Larsen PG The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand 1985;634 (Suppl): 1-70.
12. Vassenden K. Folke- og boligtellingene 1960, 1970 og 1980. Dokumentasjon av de sammenlignbare filene. Report 87/2. Oslo-Kongsvinger: Statistics Norway; 1986.
13. Gjertsen F. The Norwegian Causes of Death Register — an important data source for medical research. Tidsskr Nor Lægeforen 2002;122:2551-4.
14. Håheim LL Validation of cause of death by age. Tidsskr Nor Lægeforen 1999;119:826-830.
15. Available at http://www.ssb.no/english/subjects/03/01/10/dodsarsak_en/tab-2004-02-27-03-en.html
16. Graff-Iversen S. 40-years old female sex hormone users: Healthy selections or risk groups? Results from health surveys in 11 Norwegian counties 1997—99. Nor J Epidemiol 2001; 11:73-79.
17. Royal College of General Practitioners’ Oral Contraceptive Study. Further analyses of mortality in oral contraceptive users. Lancet 1981;March 7:541-6.
18. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptive: results of an international multicentre case-control study. Lancet 1997;349: 1202-9.
19. Njolstad I., Arnesen E., Lund-Larsen PG Smoking, serum lipids, blood pressure, and sex difference in myocardial infarction. A 12-years follow-up of the Finnmark Study. Circulation 1996;93:450-6.
20. Foulon T., Payen N., Laporte F., et al. Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size. Contraception 2001;46:11-16.
21. Chasan-Taber L., Willett W.C., Manson J.E., et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996;94: 483-9.